Biology and proteomics of extracellular vesicles: Harnessing their clinical potential

Expert Review of Proteomics

Volumn 11, Issue 3, 2014, Pages 251-253

  D'Souza Schorey, Crislyn ^a   Di Vizio, Dolores ^b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

disease biomarkers; exosomes; microvesicles

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

BIOGENESIS; CANCER IMMUNOTHERAPY; CLINICAL EFFECTIVENESS; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; EXTRACELLULAR MEMBRANE VESICLE; GENE DELIVERY SYSTEM; HUMAN; INTRACELLULAR SIGNALING; LIQUID CHROMATOGRAPHY; MEDICAL TECHNOLOGY; MEMBRANE BIOLOGY; MEMBRANE VESICLE; MOLECULAR MEDICINE; PATIENT CARE; PROTEOMICS; REVIEW; TANDEM MASS SPECTROMETRY; ANIMAL; CELL COMMUNICATION; EXOSOME; IMMUNOLOGY; IMMUNOTHERAPY; MEMBRANE MICROPARTICLE; METABOLISM; NEOPLASMS; PERSONALIZED MEDICINE;

ANIMALS; BIOLOGICAL MARKERS; CELL COMMUNICATION; CELL-DERIVED MICROPARTICLES; EXOSOMES; HUMANS; IMMUNOTHERAPY; INDIVIDUALIZED MEDICINE; NEOPLASMS; PROTEOME;

EID: 84901048925     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2014.874290     Document Type: Review

References (28)

1. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009;19:43-51
2. D'Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012;26:1287-99
3. Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol 2013;200: 367-71
4. Di Vizio D, Morello M, Dudley AC, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 2012;181: 1573-84
5. Muralidharan-Chari V, Clancy J, Plou C, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 2009;19:1875-85
6. Di Vizio D, Kim J, Hager MH, et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 2009;69:5601-9
7. Lee TH, D'Asti E, Magnus N, et al. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 2011;33:455-67
8. Cossetti C, Smith JA, Iraci N, et al. Extracellular membrane vesicles and immune regulation in the brain. Front Physiol 2012;3:117
9. van Doormaal FF, Kleinjan A, Di Nisio M, et al. Cell-derived microvesicles and cancer. Neth J Med 2009;67:266-73
10. ExoCarta. Exosome protein, lipid and lipid database. Available from: www.exocarta.org/
11. Vesiclepedia. A community compendium of extracellular vesicles. Available from: http://microvesicles.org/
12. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010;73:1907-20
13. van Niel G, Raposo G, Candalh C, et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001;121:337-49
14. Skokos D, Le Panse S, Villa I, et al. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 2001;166:868-76
15. Thery C, Boussac M, Veron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001;166:7309-18
16. Choi DS, Kim DK, Kim YK, et al. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 2013;13:1554-71
17. Choi DS, Yang JS, Choi EJ, et al. The protein interaction network of extracellular vesicles derived from human colorectal cancer cells. J Proteome Res 2012;11: 1144-51
18. Tauro BJ, Greening DW, Mathias RA, et al. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 2013;12:587-98
19. Yang W, Di Vizio D, Kirchner M, et al. Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Mol Cell Proteomics 2010;9:54-70
20. Momen-Heravi F, Balaj L, Alian S, et al. Current methods for the isolation of extracellular vesicles. Biol Chem 2013;394: 1253-62
21. Hung MC, Lau YK. Basic science of HER-2/neu: a review. Semin Oncol 1999;26:51-9
22. Baran J, Baj-Krzyworzeka M, Weglarczyk K, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010;59:841-50
23. Lakhal S, Wood MJ. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays 2011;33:737-41
24. Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011;29:341-5
25. Noerholm M, Balaj L, Limperg T, et al. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 2012;12:22
26. Wu CC, MacCoss MJ. Shotgun proteomics: tools for the analysis of complex biological systems. Curr Opin Mol Ther 2002;4: 242-50
27. Mani DR, Abbatiello SE, Carr SA. Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics. BMC Bioinformatics 2012;13:S9
28. Meissner F, Scheltema RA, Mollenkopf HJ, et al. Direct proteomic quantification of the secretome of activated immune cells. Science 2013;340:475-8